The clinical efficacy and safety of Ginkgo biloba in vertigo patients: A meta-analysis

IF 1.7 Q2 Medicine

Advances in integrative medicine Pub Date : 2023-12-01 DOI:10.1016/j.aimed.2023.10.001

Xiang Gao, Yan Cheng, Fangyuan Liu, Xiaozhen Han, Chuanliang Liu

{"title":"The clinical efficacy and safety of Ginkgo biloba in vertigo patients: A meta-analysis","authors":"Xiang Gao, Yan Cheng, Fangyuan Liu, Xiaozhen Han, Chuanliang Liu","doi":"10.1016/j.aimed.2023.10.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>We detected the clinical efficacy and safety of <em>Ginkgo biloba</em> in vertigo patients through a meta-analysis method.</div></div><div><h3>Method</h3><div>PubMed, Web of Science, Embase, Cochrane, EBSCO, CBM, CNKI, and Wanfang databases were searched for randomized controlled trials. Data about the clinical efficacy and safety of vertigo patients were collected. The <em>Ginkgo biloba</em> groups were pooled to compare with the control groups and obtain the pooled odds ratios and associated 95 % confidence interval.</div></div><div><h3>Results</h3><div>We retrieved 25 randomized controlled studies enrolling 1209 patients. The addition of <em>Ginkgo biloba</em> improved vertigo in patients with vertebrobasilar artery insufficiency, cervical vertigo, and not-specific-disease vertigo but not in BPPV and Meniere’s disease. The incidence of adverse reactions such as headache, gastrointestinal discomfort, and skin rashes in the <em>Ginkgo biloba</em> group did not differ significantly from that of the control group.</div></div><div><h3>Conclusion</h3><div>The addition of <em>Ginkgo biloba</em> had better clinical efficacy in patients with vertebrobasilar artery insufficiency, cervical vertigo, and not-specific-disease vertigo but not in BPPV and Meniere’s disease, and the <em>Ginkgo biloba</em> group had no significant differences in adverse reactions compared with the control group.</div></div>","PeriodicalId":7343,"journal":{"name":"Advances in integrative medicine","volume":"10 4","pages":"Pages 158-166"},"PeriodicalIF":1.7000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in integrative medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212958823000836","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Objective

We detected the clinical efficacy and safety of Ginkgo biloba in vertigo patients through a meta-analysis method.

Method

PubMed, Web of Science, Embase, Cochrane, EBSCO, CBM, CNKI, and Wanfang databases were searched for randomized controlled trials. Data about the clinical efficacy and safety of vertigo patients were collected. The Ginkgo biloba groups were pooled to compare with the control groups and obtain the pooled odds ratios and associated 95 % confidence interval.

Results

We retrieved 25 randomized controlled studies enrolling 1209 patients. The addition of Ginkgo biloba improved vertigo in patients with vertebrobasilar artery insufficiency, cervical vertigo, and not-specific-disease vertigo but not in BPPV and Meniere’s disease. The incidence of adverse reactions such as headache, gastrointestinal discomfort, and skin rashes in the Ginkgo biloba group did not differ significantly from that of the control group.

Conclusion

The addition of Ginkgo biloba had better clinical efficacy in patients with vertebrobasilar artery insufficiency, cervical vertigo, and not-specific-disease vertigo but not in BPPV and Meniere’s disease, and the Ginkgo biloba group had no significant differences in adverse reactions compared with the control group.

查看原文本刊更多论文

银杏叶治疗眩晕患者的临床疗效和安全性:一项meta分析

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Advances in integrative medicine INTEGRATIVE & COMPLEMENTARY MEDICINE-

CiteScore

3.20

自引率

11.80%

发文量

审稿时长

15 weeks

期刊介绍： Advances in Integrative Medicine (AIMED) is an international peer-reviewed, evidence-based research and review journal that is multi-disciplinary within the fields of Integrative and Complementary Medicine. The journal focuses on rigorous quantitative and qualitative research including systematic reviews, clinical trials and surveys, whilst also welcoming medical hypotheses and clinically-relevant articles and case studies disclosing practical learning tools for the consulting practitioner. By promoting research and practice excellence in the field, and cross collaboration between relevant practitioner groups and associations, the journal aims to advance the practice of IM, identify areas for future research, and improve patient health outcomes. International networking is encouraged through clinical innovation, the establishment of best practice and by providing opportunities for cooperation between organisations and communities.